Barbour SJ - Search Results

1

Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

Floege J, Barbour SJ, Cattran DC, Hogan JJ, Nachman PH, Tang SCW, Wetzels JFM, Cheung M, Wheeler DC, Winkelmayer WC, Rovin BH; Conference Participants. Floege J, et al. Among authors: barbour sj. Kidney Int. 2019 Feb;95(2):268-280. doi: 10.1016/j.kint.2018.10.018. Kidney Int. 2019. PMID: 30665568 Free article.

2

The prevalence of hematologic and metabolic abnormalities during chronic kidney disease stages in different ethnic groups.

Barbour SJ, Er L, Djurdjev O, Karim MA, Levin A. Barbour SJ, et al. Kidney Int. 2008 Jul;74(1):108-14. doi: 10.1038/ki.2008.151. Epub 2008 Apr 23. Kidney Int. 2008. PMID: 18432185 Free article.

3

Disease-specific risk of venous thromboembolic events is increased in idiopathic glomerulonephritis.

Barbour SJ, Greenwald A, Djurdjev O, Levin A, Hladunewich MA, Nachman PH, Hogan SL, Cattran DC, Reich HN. Barbour SJ, et al. Kidney Int. 2012 Jan;81(2):190-5. doi: 10.1038/ki.2011.312. Epub 2011 Sep 14. Kidney Int. 2012. PMID: 21918501 Free article.

4

Venous thromboembolism in patients with membranous nephropathy.

Lionaki S, Derebail VK, Hogan SL, Barbour S, Lee T, Hladunewich M, Greenwald A, Hu Y, Jennette CE, Jennette JC, Falk RJ, Cattran DC, Nachman PH, Reich HN. Lionaki S, et al. Clin J Am Soc Nephrol. 2012 Jan;7(1):43-51. doi: 10.2215/CJN.04250511. Epub 2011 Nov 10. Clin J Am Soc Nephrol. 2012. PMID: 22076873 Free PMC article.

5

Risk stratification of patients with IgA nephropathy.

Barbour SJ, Reich HN. Barbour SJ, et al. Am J Kidney Dis. 2012 Jun;59(6):865-73. doi: 10.1053/j.ajkd.2012.02.326. Epub 2012 Apr 11. Am J Kidney Dis. 2012. PMID: 22497792 Review.

6

Short-term complications of membranous nephropathy.

Barbour S, Reich H, Cattran D. Barbour S, et al. Contrib Nephrol. 2013;181:143-51. doi: 10.1159/000349976. Epub 2013 May 8. Contrib Nephrol. 2013. PMID: 23689576 Review.

7

Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease.

Barbour SJ, Cattran DC, Kim SJ, Levin A, Wald R, Hladunewich MA, Reich HN. Barbour SJ, et al. Kidney Int. 2013 Nov;84(5):1017-24. doi: 10.1038/ki.2013.210. Epub 2013 Jun 5. Kidney Int. 2013. PMID: 23739233 Free article.

8

Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy.

Lee T, Biddle AK, Lionaki S, Derebail VK, Barbour SJ, Tannous S, Hladunewich MA, Hu Y, Poulton CJ, Mahoney SL, Charles Jennette J, Hogan SL, Falk RJ, Cattran DC, Reich HN, Nachman PH. Lee T, et al. Among authors: barbour sj. Kidney Int. 2014 Jun;85(6):1412-20. doi: 10.1038/ki.2013.476. Epub 2013 Dec 11. Kidney Int. 2014. PMID: 24336031 Free PMC article.

9

Advances in the understanding of complement mediated glomerular disease: implications for recurrence in the transplant setting.

Barbour S, Gill JS. Barbour S, et al. Am J Transplant. 2015 Feb;15(2):312-9. doi: 10.1111/ajt.13042. Am J Transplant. 2015. PMID: 25612487 Free article. Review.

10

The need for improved uptake of the KDIGO glomerulonephritis guidelines into clinical practice in Canada: a survey of nephrologists.

Barbour S, Beaulieu M, Gill J, Espino-Hernandez G, Reich HN, Levin A. Barbour S, et al. Clin Kidney J. 2014 Dec;7(6):538-45. doi: 10.1093/ckj/sfu104. Epub 2014 Oct 24. Clin Kidney J. 2014. PMID: 25859369 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

90 results

Search Page